An increasing number of studies are now exploring the potential of using blood-based biomarkers for prediction of antipsychotic treatment response in studies of schizophrenia patients. Here we describe the detailed… Click to show full abstract
An increasing number of studies are now exploring the potential of using blood-based biomarkers for prediction of antipsychotic treatment response in studies of schizophrenia patients. Here we describe the detailed setup of a clinical study to identify biomarker candidates for prediction of response of patients prior to receiving antipsychotics over a 6-week treatment period. The main emphasis is on study design, patient recruitment, sampling and outcome measures.
               
Click one of the above tabs to view related content.